Skip to main content
. 2021 Apr 16;10(5):511–520. doi: 10.1530/EC-21-0045

Table 5.

Concentrations of steroids in 70-year-old men (n = 371) after excluding persons on glucocorticoid therapy (n = 4), hormone treatment (n = 19) and/or lipid lowering medication (n = 81), by BMI categories normal weight, (BMI < 25 kg/m2) overweight (BMI 25–30 kg/m2) and obese (BMI > 30 kg/m2), presented as median and the 2.5 and 97.5 percentile values (i.e. the central 95%). BMI category comparisons were made applying the non-parametric Kruskal–Wallis test.

Variable Normal weight Over weight Obese P-valuea
n Median (2.5th, 97.5th percentiles) n Median (2.5th, 97.5th percentiles) n Median (2.5th, 97.5th percentiles)
Estrone (pmol/L) 122 94.3 (31.4, 184) 191 89.9 (28.5, 192) 58 112 (44.4, 261) <0.005*
Estradiol (pmol/L) 122 62.0 (21.5, 141) 191 57.9 (15.8, 147) 58 75.4 (11.2, 131) 0.03
11-deoxycortisol (nmol/L) 121 0.979 (0.317, 2.51) 191 0.749 (0.259, 2.94) 57 0.95 (0.253,3.43) <0.005*
Testosterone (nmol/L) 121 16.9 (9.37, 29.4) 191 13.1 (6.91, 28.0) 57 11.3 (4.20, 18.7) <0.005*
Dehydroepi-androsterone (nmol/L) 121 9.02 (2.05, 25.3) 191 7.08 (2.46, 21.0) 57 7.60 (1.90, 22.6) <0.005*
Androstenedione (nmol/L) 121 2.12 (1.15, 3.61) 191 1.87 (0.832, 4.03) 57 1.84 (0.892, 5.76) <0.005*
17-hydroxypregnenolone (nmol/L) 121 2.98 (0.810, 8.52) 191 2.02 (0.696, 8.70) 57 2.08 (0.686, 10.4) <0.005*
Pregnenolone (nmol/L) 121 3.35 (1.51, 7.33) 191 3.00 (1.29, 6.45) 57 3.03 (1.05, 6.38) 0.02
17-hydroxyprogesterone (nmol/L) 121 2.55 (1.24, 4.64) 191 1.93 (0.788, 5.18) 57 1.97 (0.757, 10.5) <0.005*
Sex hormone-binding globulin (nmol/L) 118 52.9 (22.4, 99.7) 184 39.1 (19.1, 91,5) 58 37.8 (17.9, 59.1) <0.005*

aKruskal–Wallis test was used to test differences between BMI categories; *indicates statistical significance after adjusting the P-values for multiplicity using Bonferroni correction (0.05/10); P-value for significance 0.005.